Why cancer treatment in India is cheaper as compared to other countries
Cancer treatment in India is not only cheaper but in most cases the prognosis is amongst the best in the world.
Neuroendocrine Tumours: Management and Treatment
A Neuroendocrine Tumour or NET is a specific tumour affecting the endocrine glands. Specifically a variant known as the Carcinoid Tumour is very common and lethal. Early detection and management is the key.
The paradox of tobacco and cigarettes in India
While the ban of smoking and tobacco would help health matters, the economic loss to the government is immense..Is there a way to balance the two ?
How pollution might be damaging your skin?
Your skin wants to protect you. It protects your muscles and organs from the elements, and it is strong enough to stand up to the stresses we put on it on a daily basis. But skin can’t withstand everything we throw at it, and there are several things we encounter on a daily basis that can irritate and damage the skin.
The sun, of course, is one factor that can cause the skin to become damaged and prematurely aged. Most people know this, and make an effort to prevent skin cancer using sunscreen and common sense. Unfortunately, there’s another factor that can damage the skin—and you may not even notice it. Pollution, a major issue in urban areas, can have a major negative impact on your skin without you even realizing it. To know more we spoke to Dr. Sravya C Tipirneni, Consultant Dermatologist & Cosmetologist, Columbia Asia Hospital, Whitefield.
Genetic profiling tests may hold the key for beating Cancer
It is vital for oncologists to get clinically actionable and timely results to decide on treatment options for patients. Keeping this in mind, StrandAdvantage, a tumor genomic profiling test by Strand Life Sciences, was launched in India about a year ago.
Strand Life Sciences is a global genomic profiling & bioinformatics company focusing on the use of precision medicine diagnostics aimed at cancer care and inherited diseases.In 2016, Strand made its new 152-gene test available to physicians across India for expanded tumor profiling, compared to the existing Tissue-Specific Tests for colon, lung, and breast cancers, and the 48-gene test for rare and aggressive cancers.